The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods

Leukemia & Lymphoma
Eugenio LuciaFortunato Morabito

Abstract

A recurrent specific JAK2 V617F mutation has been reported in bcr/abl-negative chronic myeloproliferative diseases (cMPD), including polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF). The mutation is detectable in a variable proportion of neoplastic clones, depending on the molecular methods employed. In this study, we attempted to establish the JAK2 V617F mutation frequency in two partially overlapping cMPD patient series by two different PCR-based techniques. Using an allele-specific polymerase chain reaction assay (AS-PCR), the JAK2 V617F mutation was detected in 124/158 (78.5%) cMPD patients; in particular, 90.2, 72.1, 63.2 and 50% of PV, ET, IMF and unclassified (U)-MPD cases, respectively, showed the mutation. Employing a semiquantitative 5' fluorogenic TaqMan assay, the JAK2 V617F mutation was identified in a much larger percentage of cMPDs patients (118/127: 92.9%). Rates of mutation in PV, ET, IMF and U-MPD cases were 95.9, 85.7, 91.7 and 92.9%, respectively. Furthermore, a statistically higher percentage of JAK2 mutated alleles was detected by TaqMan assay in PV (68+/-3.5, mean value+/-SEM) and IMF (64+/-9.3) cases as compared with ET (35+/-5.4). Finally, a significant correlati...Continue Reading

References

Sep 20, 2002·Blood·James W VardimanRichard D Brunning
Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
May 3, 2005·The Journal of Biological Chemistry·Runxiang ZhaoZhizhuang Joe Zhao
Oct 4, 2005·British Journal of Haematology·Alexandra P WolanskyjAyalew Tefferi
Dec 3, 2005·Leukemia & Lymphoma·Maria E Nelson, David P Steensma
Sep 2, 2006·Blood·Xuesong XuZhizhuang Joe Zhao
Dec 8, 2006·The New England Journal of Medicine·Peter J Campbell, Anthony R Green
Jan 27, 2007·Current Opinion in Hematology·Ayalew Tefferi, James W Vardiman
May 19, 2007·American Journal of Clinical Pathology·Angela Y C TanAlexander Dobrovic
Jul 13, 2007·Leukemia·A M VannucchiUNKNOWN MPD Research Consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.